Addex Therapeutics Ltd
Addex Therapeutics Ltd (ADXN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ADXN · as of Sep 30, 2023
Ownership Breakdown
5
Institutional Holders
▲ 2 vs Q2
$287,016
Total Inst. Value
▲ $45,474 vs Q2
720,250
Shares Outstanding
freeFloat 80.34%
746,855
13F Shares Held
▲ 283,242 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ADXN largest shareholders · institutional ownership
Q3 2023 · SEC 13F
Showing top 5 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC pharmaceutical preparations | 537.0K | 4.46% | 4.46% | $206.37M | Nov 14, 2023 | ▲ 273.0K |
NEA MANAGEMENT COMPANY, LLC pharmaceutical preparations | 180.0K | 1.50% | 1.50% | $408.29M | Nov 14, 2023 | — held |
BAADER BANK AKTIENGESELLSCHAFT pharmaceutical preparations | 19.2K | 15.96% | 15.96% | $6.58M | Nov 14, 2023 | ▼ 410 |
JANE STREET GROUP, LLC pharmaceutical preparations | 10.6K | 8.79% | 8.79% | $4.07M | Nov 15, 2023 | ▲ 10.6K |
UBS GROUP AG pharmaceutical preparations | 74 | 0.06% | 0.06% | $28,000 | Nov 9, 2023 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2023 vs prior quarter
Q3 2023
2
Increased
+283.6K shares1
New Positions
first time holders1
Decreased
−410 shares0
Sold Out
fully exitedNet shares change (top 50)
+283.2K
+283.6K / −410
Net new holders
+2
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ADXN insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Addex Therapeutics Ltd (ADXN) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 19.66%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Addex Therapeutics Ltd is ARMISTICE CAPITAL, LLC, holding approximately 537,000 shares — equal to 4.46% of outstanding shares — as of September 30, 2023.
A total of 5 institutional investors currently hold ADXN stock, with a combined institutional value of approximately $287,016 as of the most recent 13F filing period.
Frequently asked questions
ADXN ownershipAddex Therapeutics Ltd (ADXN) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is ARMISTICE CAPITAL, LLC with a 4.46% stake. Company insiders hold 19.66%. Data sourced from SEC Form 13F as of September 30, 2023.